AVEO to present data on tivozanib Phase 1b trial for breast cancer at SABCS Symposium AVEO Pharmaceuticals, Inc. Gonzalez Convention Middle in San Antonio, Texas.D., Sc.M., chief medical officer at AVEO. We look forward to sharing the brand new data from our ongoing Phase 1b clinical trial evaluating tivozanib in combination with paclitaxel with the breast cancer community. The details for the AVEO poster presentation at SABCS are the following: Date & Time: Friday, December 10, 2010 from 7:00-9:00 a.m.Kaiser Family Foundation. Copyright 2006 Advisory Board Company and Kaiser Family Basis. All rights reserved.
FDA Bans Sale of New R.J. Reynolds Cigarettes: – TUESDAY, Sept. 15, 2015 – – The U.S. Drug and Food Administration provides ordered the R.J. Reynolds Tobacco Co. To avoid selling four brand-new cigarette brands because they violate provisions of this year’s 2009 tobacco control laws. The agency identified that the smokes are substantially different from existing Reynolds tobacco items in the marketplace and need a full agency critique before they may be marketed.